CMAR_A_337497 8341..8352
暂无分享,去创建一个
Xiaojie Pan | Y. Huang | Lili Yu | Xiaoqing Yin | Yulong Sun | Liqing Cai | Mingshu Tu | Liangming Zhang | Tao Wang | Jianwei Wang
[1] Yingling Liu,et al. CST1 Promoted Gastric Cancer Migration and Invasion Through Activating Wnt Pathway , 2021, Cancer management and research.
[2] J. Kos,et al. Cystatins in cancer progression: More than just cathepsin inhibitors. , 2019, Biochimie.
[3] Yufeng Liu,et al. Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis , 2019, Journal of cellular physiology.
[4] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[5] Yibo Gao,et al. Immunohistochemical prognostic markers of esophageal squamous cell carcinoma: a systematic review , 2017, Chinese journal of cancer.
[6] Weidong Wei,et al. Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis , 2017, Journal of Molecular Medicine.
[7] Bin Wu,et al. Identification of cystatin SN as a novel biomarker for pancreatic cancer , 2015, Tumor Biology.
[8] J. Ferlay,et al. Global incidence of oesophageal cancer by histological subtype in 2012 , 2014, Gut.
[9] J. Lagergren,et al. The risk of esophageal adenocarcinoma after antireflux surgery. , 2010, Gastroenterology.
[10] Seon-Young Kim,et al. Upregulation of the cysteine protease inhibitor, cystatin SN, contributes to cell proliferation and cathepsin inhibition in gastric cancer. , 2009, Clinica chimica acta; international journal of clinical chemistry.
[11] H. Aburatani,et al. Identification of Cystatin SN as a novel tumor marker for colorectal cancer. , 2009, International journal of oncology.
[12] Chin-Lee Wu,et al. Cystatin B As a Tissue and Urinary Biomarker of Bladder Cancer Recurrence and Disease Progression , 2009, Clinical Cancer Research.
[13] K. Hatakeyama,et al. Clinical Significance of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, and Squamous Cell Carcinoma Antigen Levels in Esophageal Cancer Patients , 2004, World Journal of Surgery.
[14] Kathleen R. Cho,et al. Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas. , 2003, Cancer research.
[15] H. Matsubara,et al. Prognostic significance of CYFRA 21-1 in patients with esophageal squamous cell carcinoma. , 2003, Journal of the American College of Surgeons.
[16] A. Barrett,et al. Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. , 1986, The Journal of biological chemistry.
[17] A. Barrett,et al. Cystatin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detection in chicken serum. , 1983, The Biochemical journal.
[18] María José Domper Arnal,et al. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. , 2015, World journal of gastroenterology.
[19] D. P. Dickinson,et al. Genomic cloning, physical mapping, and expression of human type 2 cystatin genes. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[20] P. Asbell,et al. Cystatins in human tear fluid. , 1991, Current eye research.